Dr Girija Anand

MBBS, MRCP, FRCR

Special clinical interest in breast, lung and skin.

LANGUAGES

English

Professional profile

Dr Girija (Gij) Anand was appointed as a consultant in clinical oncology at North Middlesex University Hospital NHS Trust in January 2011. She also works at the Royal Free Hospital Chase Farm site.

She obtained her MRCP in 2002. Gij completed higher specialist training in clinical oncology at Mount Vernon Hospital, North Middlesex Hospital, Royal Free Hospital and Imperial College NHS Trust. She became a fellow of the Royal College of Radiologists in September 2007 and completed higher specialist training in February 2009.

Dr Anand has wide experience in the general oncological management of various tumour sites. Dr Anand has particular expertise in treating tumors of the lung, breast, and skin (non melanoma) malignancies. Her practice includes the delivery of novel radiotherapy techniques and medical oncology.

She has an active interest in research, teaching and recruits into national and commercial clinical trials. Another key area of interest is service development in the modern NHS.

Her subsequent roles included radiotherapy lead for London cancer skin pathway board established to streamline skin cancer pathways across north central London(2012-2017).

Clinical Director for oncology & palliative care at North Middlesex (2014-2018). Currently Radiotherapy Stratgeic lead for Royal Free London & North Middlesex University Hospitals. From September 2019 she will take on the role of Faculty member for Clinical Oncology at the Royal College of Radiologists.

NHS Hospital

North Middlesex NHS Trust

Year Qualified

1998

Research Interests

Active recruiter into National & commerial clinical trials in breast & lung cancer

Professional memberships
Royal College of Radiologists.

Awards Received

Gold Medalist in Opthalmology MBBS

Publications

1. Phylogenetic ctDNA analysis depicts early stage lung cancer evolution, C Abbosh, TRACER X consortium(G Anand), C Swanton et al Nature 545, 446-451 (25 May 2017)

2. Tracking the Evolution of Non Small Cell Lung Cancer, M Jamal-Hanjani, TRACER X consortium(G Anand), C Swanton et al N England, Journal of Medicine 2017, 376: 2109-2121

3.Palliative Radiotherapy for Merkell Cell Carcinoma; Single centre experience and review of the literature, B Kanagaratnam, A Shah and G Anand, Journal of Radiotherapy in Practice

Specialities

  • Oncology

Centres